Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
Published on: November 10, 2023
Nanoparticle-based immunotherapy for cancer
Kun Shao1, Santiswarup Singha, Xavier Clemente-Casares
1Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cummings School of Medicine, University of Calgary , Calgary, Alberta T2N 4N1 Canada.
Abstract:
The design of nanovaccines capable of triggering effective antitumor immunity requires an understanding of how the immune system senses and responds to threats, including pathogens and tumors. Equally important is an understanding of the mechanisms employed by tumor cells to evade immunity and an appreciation of the deleterious effects that antitumor immune responses can have on tumor growth, such as by skewing tumor cell composition toward immunologically silent tumor cell variants. The immune system and tumors engage in a tug-of-war driven by competition where promoting antitumor immunity or tumor cell death alone may be therapeutically insufficient. Nanotechnology affords a unique opportunity to develop therapeutic compounds than can simultaneously tackle both aspects, favoring tumor eradication. Here, we review the current status of nanoparticle-based immunotherapeutic strategies for the treatment of cancer, ranging from antigen/adjuvant delivery vehicles (to professional antigen-presenting cell types of the immune system) to direct tumor antigen-specific T-lymphocyte-targeting compounds and their combinations thereof.
Insights
Nanovaccines leverage nanotechnology to enhance antitumor immunity by overcoming tumor evasion mechanisms. This review explores nanoparticle-based immunotherapies for cancer treatment, combining antigen delivery and immune cell targeting for tumor eradication.
Area of Science:
- Immunology
- Nanotechnology
- Oncology
Background:
- Effective antitumor immunity requires understanding immune responses to threats like tumors.
- Tumor cells evade immunity, and immune responses can paradoxically promote tumor growth.
- The interplay between the immune system and tumors is a complex competition.
Purpose of the Study:
- To review nanoparticle-based immunotherapeutic strategies for cancer treatment.
- To highlight how nanotechnology can address both immune evasion and tumor growth.
- To explore diverse nanoparticle applications in cancer immunotherapy.
Main Methods:
- Review of current literature on nanoparticle-based cancer immunotherapies.
- Analysis of strategies for antigen/adjuvant delivery to antigen-presenting cells.
- Examination of T-lymphocyte-targeting compounds and combination therapies.
Main Results:
- Nanoparticles offer a unique platform for simultaneous immune stimulation and tumor targeting.
- Current strategies include antigen/adjuvant delivery systems and direct immune cell targeting.
- Combinations of nanoparticle-based approaches show promise for enhanced efficacy.
Conclusions:
- Nanotechnology is crucial for developing advanced nanovaccines against cancer.
- Simultaneously addressing immune evasion and tumor growth is key for therapeutic success.
- Nanoparticle-based immunotherapies represent a promising frontier in cancer treatment.
More Related Videos
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...